HCM, Genetic Testing, and Sudden Cardiac Death Risk Prediction: Study Validates New Guidelines

This chapter explores the genetic causes of hypertrophic cardiomyopathy (HCM) and emphasizes the importance of genetic testing for patients and families. It also discusses a recent study validating changes in sudden cardiac death risk prediction guidelines, highlighting the role of imaging risk markers and the influence of genetics on future risk stratification.